(19)
(11) EP 4 196 615 A1

(12)

(43) Date of publication:
21.06.2023 Bulletin 2023/25

(21) Application number: 21856849.1

(22) Date of filing: 16.08.2021
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
C12Q 1/6883(2018.01)
C12Q 1/6876(2018.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C12Q 1/6886; A61P 35/04; C12Q 2600/16; C12Q 2600/118; C12Q 2600/158
(86) International application number:
PCT/US2021/046105
(87) International publication number:
WO 2022/036308 (17.02.2022 Gazette 2022/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.08.2020 US 202016993401

(71) Applicant: Castle Biosciences, Inc.
Friendswood, TX 77546 (US)

(72) Inventors:
  • COOK, Robert, Willis
    Friendswood, TX 77546 (US)
  • COVINGTON, Kyle, R.
    Friendwood, TX 77546 (US)
  • MAETZOLD, Derek
    Friendwood, TX 77546 (US)
  • KURLEY, Sarah, J.
    Friendwood, TX 77546 (US)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA